专利号:WO-2025077857-A1 优先权日:2023-10-13 标题:Use of prmt5 inhibitor in treatment of tumors or cancers 发明人:YAO BING; GU XIAOHUI; MAO WEIFENG; ASWAD FRED JULLIEN; JOSEPH JAMES DAVID; LI MINGXI 权利人:SHANGHAI APEIRON THERAPEUTICS COMPANY LTD 摘要:The present disclosure describes a novel molecule having protein arginine methyltransferase 5 inhibitory activity, and methods for synthesis and use of a compound. Specifically, the present disclosure describes a compound of formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, and methods for synthesis and use of the compound.
专利号:WO-2024067445-A1 优先权日:2022-09-26 标 题 :Novel prmt5 inhibitor and use thereof 发明人:YAO BING; GU XIAOHUI; ZHANG JUNQING; XIE SHANSHAN; CHENG KAI 权利人:SHANGHAI APEIRON THERAPEUTICS COMPANY LTD 摘要:Provided are a compound of formula (I) having inhibitory activity for protein arginine methyltransferase 5, and a method for synthesis and use of the compound.
参考文献:10.1055/s-0041-1738304 摘要:Synthesis of Danuglipron: An Orally Available GLP-1R Agonist. Synfacts. 2022 Aug 18;18(09):1025. doi: 10.1055/s-0041-1738304.